Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
OncoSil Medical Ltd ( (AU:OSL) ) has shared an update.
OncoSil Medical Ltd has announced a proposed issue of securities, including options expiring in 2027 and ordinary fully paid shares, with a total of 17,271 securities to be issued. This move is part of a placement or other type of issue, and the company has applied for the quotation of these securities on the ASX. The issuance is set to take place on August 8, 2025, and is expected to support the company’s operations and strategic initiatives in the oncology market.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on the development and commercialization of innovative medical devices for the treatment of cancer. The company’s primary product is a targeted radioactive implant designed to treat pancreatic and liver cancer, positioning itself in the oncology sector with a focus on improving patient outcomes.
Average Trading Volume: 42,531
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$16.71M
For a thorough assessment of OSL stock, go to TipRanks’ Stock Analysis page.